(NASDAQ: CODX) Co Diagnostics's forecast annual revenue growth rate of 215.72% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Co Diagnostics's revenue in 2025 is $1,003,653.On average, 4 Wall Street analysts forecast CODX's revenue for 2025 to be $20,157,850, with the lowest CODX revenue forecast at $8,041,413, and the highest CODX revenue forecast at $32,885,656. On average, 4 Wall Street analysts forecast CODX's revenue for 2026 to be $26,523,486, with the lowest CODX revenue forecast at $0, and the highest CODX revenue forecast at $54,626,439.
In 2027, CODX is forecast to generate $1,532,468,092 in revenue, with the lowest revenue forecast at $1,472,371,304 and the highest revenue forecast at $1,577,540,683.